{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:26:04Z","timestamp":1787682364029,"version":"build-2784847793"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Taiwan Ministry of Health and Welfare Clinical Trial Center","award":["MOHW112-TDU-B-212-144004"],"award-info":[{"award-number":["MOHW112-TDU-B-212-144004"]}]},{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","award":["DMR-111-105"],"award-info":[{"award-number":["DMR-111-105"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","award":["DMR-112-087"],"award-info":[{"award-number":["DMR-112-087"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","award":["DMR-113-009"],"award-info":[{"award-number":["DMR-113-009"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"DOI":"10.1007\/s12072-026-11117-0","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T07:51:46Z","timestamp":1783410706000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["New oral anticoagulants and hepatocellular carcinoma among patients with HBV, HCV, and alcoholic liver diseases: a nationwide cohort study"],"prefix":"10.1007","author":[{"given":"Yu-Wen","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hsuan","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Min","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuu-Jen","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1016-2233","authenticated-orcid":false,"given":"Renin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Shuo","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"issue":"3","key":"11117_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"key":"11117_CR2","unstructured":"Health Promotion Administration MoHaW, Taiwan Cancer registry annual report, 2022, Taiwan. 2024. p. 40\u20131."},{"issue":"1","key":"11117_CR3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jhep.2021.02.029","volume":"75","author":"SH Liao","year":"2021","unstructured":"Liao SH, Chen CL, Hsu CY, Chien KL, Kao JH, Chen PJ, et al. Long-term effectiveness of population-wide multifaceted interventions for hepatocellular carcinoma in Taiwan. J Hepatol. 2021;75(1):132\u2013141","journal-title":"J Hepatol"},{"issue":"1","key":"11117_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"11117_CR5","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cgh.2021.01.005","volume":"20","author":"H Hagstr\u00f6m","year":"2022","unstructured":"Hagstr\u00f6m H, Thiele M, Sharma R, Simon TG, Roelstraete B, S\u00f6derling J, et al. Risk of cancer in biopsy-proven alcohol-related liver disease: a population-based cohort study of 3410 persons. Clin Gastroenterol Hepatol. 2022;20(4):918\u201329.e8","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"11117_CR6","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jhep.2012.11.045","volume":"58","author":"CW Lin","year":"2013","unstructured":"Lin CW, Lin CC, Mo LR, Chang CY, Perng DS, Hsu CC, et al. Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis. J Hepatol. 2013;58(4):730\u2013735","journal-title":"J Hepatol"},{"issue":"22","key":"11117_CR7","doi-asserted-by":"publisher","first-page":"6770","DOI":"10.3390\/jcm13226770","volume":"13","author":"N Polpichai","year":"2024","unstructured":"Polpichai N, Saowapa S, Danpanichkul P, Chan SY, Sierra L, Blagoie J, et al. Beyond the liver: a comprehensive review of strategies to prevent hepatocellular carcinoma. J Clin Med. 2024;13(22):6770","journal-title":"J Clin Med"},{"issue":"1","key":"11117_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13045-020-00932-z","volume":"13","author":"D Unruh","year":"2020","unstructured":"Unruh D, Horbinski C. Beyond thrombosis: the impact of tissue factor signaling in cancer. J Hematol Oncol. 2020;13(1):93","journal-title":"J Hematol Oncol"},{"issue":"3","key":"11117_CR9","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1055\/s-0043-1776875","volume":"50","author":"K Aleksandrowicz","year":"2024","unstructured":"Aleksandrowicz K, Hempel D, Polity\u0144ska B, Wojtukiewicz AM, Honn KV, Tang DG, et al. The complex role of thrombin in cancer and metastasis: focus on interactions with the immune system. Semin Thromb Hemost. 2024;50(3):462\u2013473","journal-title":"Semin Thromb Hemost"},{"issue":"18","key":"11117_CR10","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1158\/0008-5472.CAN-14-2887-T","volume":"75","author":"A Kirane","year":"2015","unstructured":"Kirane A, Ludwig KF, Sorrelle N, Haaland G, Sandal T, Ranaweera R, et al. Warfarin blocks gas6-mediated Axl activation required for pancreatic cancer epithelial plasticity and metastasis. Cancer Res. 2015;75(18):3699\u20133705","journal-title":"Cancer Res"},{"issue":"1","key":"11117_CR11","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/jop.13125","volume":"50","author":"Z Lin","year":"2021","unstructured":"Lin Z, Ling LR, Ng M, Matlub L, Mehta K, Linus RA, et al. The effect of anticoagulants on oral squamous cell carcinoma: a systematic review. J Oral Pathol Med. 2021;50(1):118\u2013121","journal-title":"J Oral Pathol Med"},{"issue":"3","key":"11117_CR12","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/odi.14546","volume":"30","author":"HMA Al-Azzawi","year":"2024","unstructured":"Al-Azzawi HMA, Hamza SA, Lin Z, Paolini R, McCullough M, Yap T, et al. Potential effects of anticoagulants in preclinical mice models of oral cancer: a systematic review. Oral Dis. 2024;30(3):962\u2013965","journal-title":"Oral Dis"},{"issue":"12","key":"11117_CR13","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1001\/jamainternmed.2017.5512","volume":"177","author":"GS Haaland","year":"2017","unstructured":"Haaland GS, Falk RS, Straume O, Lorens JB. Association of warfarin use with lower overall cancer incidence among patients older than 50 years. JAMA Intern Med. 2017;177(12):1774\u20131780","journal-title":"JAMA Intern Med"},{"key":"11117_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.thromres.2019.12.022","volume":"187","author":"S Najidh","year":"2020","unstructured":"Najidh S, Versteeg HH, Buijs JT. A systematic review on the effects of direct oral anticoagulants on cancer growth and metastasis in animal models. Thromb Res. 2020;187:18\u201327","journal-title":"Thromb Res"},{"issue":"6","key":"11117_CR15","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/jth.14443","volume":"17","author":"JT Buijs","year":"2019","unstructured":"Buijs JT, Laghmani EH, van den Akker RFP, Tieken C, Vletter EM, van der Molen KM, et al. The direct oral anticoagulants rivaroxaban and dabigatran do not inhibit orthotopic growth and metastasis of human breast cancer in mice. J Thromb Haemost. 2019;17(6):951\u2013963","journal-title":"J Thromb Haemost"},{"issue":"1","key":"11117_CR16","doi-asserted-by":"publisher","first-page":"6272","DOI":"10.1038\/s41598-019-42738-1","volume":"9","author":"S Featherby","year":"2019","unstructured":"Featherby S, Xiao YP, Ettelaie C, Nikitenko LL, Greenman J, Maraveyas A. Low molecular weight heparin and direct oral anticoagulants influence tumour formation, growth, invasion and vascularisation by separate mechanisms. Sci Rep. 2019;9(1):6272","journal-title":"Sci Rep"},{"issue":"1","key":"11117_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1053\/j.gastro.2019.03.070","volume":"157","author":"JG O\u2019Leary","year":"2019","unstructured":"O\u2019Leary JG, Greenberg CS, Patton HM, Caldwell SH. AGA clinical practice update: coagulation in cirrhosis. Gastroenterology. 2019;157(1):34-43.e1","journal-title":"Gastroenterology"},{"key":"11117_CR18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2147\/CLEP.S196293","volume":"11","author":"CY Hsieh","year":"2019","unstructured":"Hsieh CY, Su CC, Shao SC, Sung SF, Lin SJ, Kao Yang YH, et al. Taiwan\u2019s national health insurance research database: past and future. Clin Epidemiol. 2019;11:349\u2013358","journal-title":"Clin Epidemiol"},{"issue":"12","key":"11117_CR19","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1200\/JCO.2012.44.6831","volume":"31","author":"YT Tsan","year":"2013","unstructured":"Tsan YT, Lee CH, Ho WC, Lin MH, Wang JD, Chen PC. Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection. J Clin Oncol. 2013;31(12):1514\u20131521","journal-title":"J Clin Oncol"},{"issue":"11","key":"11117_CR20","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1200\/JCO.21.01802","volume":"40","author":"YC Shen","year":"2022","unstructured":"Shen YC, Hsu HC, Lin TM, Chang YS, Hu LF, Chen LF, et al. H1-Antihistamines reduce the risk of hepatocellular carcinoma in patients with hepatitis B virus, hepatitis C virus, or dual hepatitis B virus-hepatitis C virus infection. J Clin Oncol. 2022;40(11):1206\u20131219","journal-title":"J Clin Oncol"},{"issue":"8","key":"11117_CR21","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1136\/gutjnl-2020-321932","volume":"70","author":"CY Wu","year":"2020","unstructured":"Wu CY, Ho HJ, Wu CY, Chen YJ, Lee TY, Hsu YC, et al. Association between proton pump inhibitor use and mortality in patients with hepatocellular carcinoma receiving tyrosine kinase inhibitor. Gut. 2020;70(8):1598\u20131599","journal-title":"Gut"},{"issue":"1","key":"11117_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/pds.3334","volume":"22","author":"ES Johnson","year":"2013","unstructured":"Johnson ES, Bartman BA, Briesacher BA, Fleming NS, Gerhard T, Kornegay CJ, et al. The incident user design in comparative effectiveness research. Pharmacoepidemiol Drug Saf. 2013;22(1):1\u20136","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"29","key":"11117_CR23","doi-asserted-by":"publisher","first-page":"4834","DOI":"10.1200\/JCO.2009.22.6324","volume":"27","author":"RS Kasthuri","year":"2009","unstructured":"Kasthuri RS, Taubman MB, Mackman N. Role of tissue factor in cancer. J Clin Oncol. 2009;27(29):4834\u20134838","journal-title":"J Clin Oncol"},{"issue":"1","key":"11117_CR24","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1186\/s13063-020-04675-7","volume":"21","author":"J Castle","year":"2020","unstructured":"Castle J, Blower E, Bundred NJ, Harvey JR, Thachil J, Marshall A, et al. Rivaroxaban compared to no treatment in ER-negative stage I-III early breast cancer patients (the TIP Trial): study protocol for a phase II preoperative window-of-opportunity study design randomised controlled trial. Trials. 2020;21(1):749","journal-title":"Trials"},{"issue":"10","key":"11117_CR25","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.4161\/cbt.10.10.13236","volume":"10","author":"K DeFeo","year":"2010","unstructured":"DeFeo K, Hayes C, Chernick M, Ryn JV, Gilmour SK. Use of dabigatran etexilate to reduce breast cancer progression. Cancer Biol Ther. 2010;10(10):1001\u20131008","journal-title":"Cancer Biol Ther"},{"issue":"39","key":"11117_CR26","doi-asserted-by":"publisher","first-page":"eaaw8405","DOI":"10.1126\/sciimmunol.aaw8405","volume":"4","author":"C Graf","year":"2019","unstructured":"Graf C, Wilgenbus P, Pagel S, Pott J, Marini F, Reyda S, et al. Myeloid cell-synthesized coagulation factor X dampens antitumor immunity. Sci Immunol. 2019;4(39):eaaw8405","journal-title":"Sci Immunol"},{"issue":"1","key":"11117_CR27","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1055\/s-0042-1758855","volume":"7","author":"K Hiramoto","year":"2023","unstructured":"Hiramoto K, Akita N, Nishioka J, Suzuki K. Edoxaban, a factor Xa-specific direct oral anticoagulant, significantly suppresses Tumor growth in colorectal cancer Colon26-inoculated BALB\/c Mice. TH Open. 2023;7(1):e1\u2013e13","journal-title":"TH Open"},{"issue":"16","key":"11117_CR28","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1002\/cam4.6332","volume":"12","author":"PA Rees","year":"2023","unstructured":"Rees PA, Castle J, Clouston HW, Lamb R, Singh U, Duff SE, et al. The effects of coagulation factors and their inhibitors on proliferation and migration in colorectal cancer. Cancer Med. 2023;12(16):1714\u201317192","journal-title":"Cancer Med"},{"issue":"13","key":"11117_CR29","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.3390\/cells12131712","volume":"12","author":"C Airola","year":"2023","unstructured":"Airola C, Pallozzi M, Cerrito L, Santopaolo F, Stella L, Gasbarrini A, et al. Microvascular thrombosis and liver fibrosis progression: mechanisms and clinical applications. Cells. 2023;12(13):1712","journal-title":"Cells"},{"issue":"12","key":"11117_CR30","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1002\/hep4.1781","volume":"5","author":"A Zanetto","year":"2021","unstructured":"Zanetto A, Campello E, Bulato C, Gavasso S, Saggiorato G, Shalaby S, et al. More pronounced hypercoagulable state and hypofibrinolysis in patients with cirrhosis with versus without HCC. Hepatol Commun. 2021;5(12):1987\u20132000","journal-title":"Hepatol Commun"},{"issue":"6","key":"11117_CR31","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1111\/liv.15183","volume":"42","author":"A Zanetto","year":"2022","unstructured":"Zanetto A, Campello E, Pelizzaro F, Farinati F, Burra P, Simioni P, et al. Haemostatic alterations in patients with cirrhosis and hepatocellular carcinoma: laboratory evidence and clinical implications. Liver Int. 2022;42(6):1229\u20131240","journal-title":"Liver Int"},{"issue":"1","key":"11117_CR32","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s10620-018-5311-1","volume":"64","author":"KC Lee","year":"2019","unstructured":"Lee KC, Hsu WF, Hsieh YC, Chan CC, Yang YY, Huang YH, et al. Dabigatran reduces liver fibrosis in Thioacetamide-injured rats. Dig Dis Sci. 2019;64(1):102\u2013112","journal-title":"Dig Dis Sci"},{"issue":"5","key":"11117_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22287","volume":"33","author":"NI Mahmoud","year":"2019","unstructured":"Mahmoud NI, Messiha BAS, Abo-Saif AA, Abdel-Bakky MS. Inhibition of activated factor X; a new pathway in ameliorating carbon tetrachloride-induced liver fibrosis in rats. J Biochem Mol Toxicol. 2019;33(5): e22287","journal-title":"J Biochem Mol Toxicol"},{"issue":"6","key":"11117_CR34","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1002\/hep.29084","volume":"65","author":"M Vilaseca","year":"2017","unstructured":"Vilaseca M, Garc\u00eda-Calder\u00f3 H, Lafoz E, Garc\u00eda-Irigoyen O, Avila MA, Reverter JC, et al. The anticoagulant rivaroxaban lowers portal hypertension in cirrhotic rats mainly by deactivating hepatic stellate cells. Hepatology. 2017;65(6):2031\u20132044","journal-title":"Hepatology"},{"issue":"1","key":"11117_CR35","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13046-018-0858-4","volume":"37","author":"T Xiao","year":"2018","unstructured":"Xiao T, Zhang Q, Zong S, Zhong W-l, Qin Y, Bi Z, et al. Protease-activated receptor-1 (PAR1) promotes epithelial-endothelial transition through Twist1 in hepatocellular carcinoma. J Exp Clin Cancer Res. 2018;37(1):185","journal-title":"J Exp Clin Cancer Res"},{"issue":"8","key":"11117_CR36","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1055\/a-1778-1083","volume":"122","author":"M Goldin","year":"2022","unstructured":"Goldin M, Koulas I, Weitz JI, Spyropoulos AC. State-of-the-art mini review: dual-pathway inhibition to reduce arterial and venous Thromboembolism. Thromb Haemost. 2022;122(8):1279\u20131287","journal-title":"Thromb Haemost"},{"issue":"3","key":"11117_CR37","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1161\/CIRCRESAHA.118.313155","volume":"124","author":"NC Chan","year":"2019","unstructured":"Chan NC, Weitz JI. Antithrombotic agents. Circ Res. 2019;124(3):426\u2013436","journal-title":"Circ Res"},{"issue":"5","key":"11117_CR38","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1111\/jth.15673","volume":"20","author":"SD Berkowitz","year":"2022","unstructured":"Berkowitz SD, Bauersachs RM, Szarek M, Nehler MR, Debus ES, Patel MR, et al. Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: dual anticoagulant\/antiplatelet regimen vs antiplatelet therapy alone. J Thromb Haemost. 2022;20(5):1193\u20131205","journal-title":"J Thromb Haemost"},{"issue":"11","key":"11117_CR39","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/NEJMoa1912035","volume":"382","author":"G Simon Tracey","year":"2020","unstructured":"Simon Tracey G, Duberg A-S, Aleman S, Chung Raymond T, Chan Andrew T, Ludvigsson JF. Association of aspirin with hepatocellular carcinoma and liver-related mortality. N Engl J Med. 2020;382(11):1018\u20131028","journal-title":"N Engl J Med"},{"issue":"19","key":"11117_CR40","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/j.jacc.2018.03.023","volume":"71","author":"A Qamar","year":"2018","unstructured":"Qamar A, Vaduganathan M, Greenberger NJ, Giugliano RP. Oral anticoagulation in patients with liver disease. J Am Coll Cardiol. 2018;71(19):2162\u20132175","journal-title":"J Am Coll Cardiol"},{"key":"11117_CR41","doi-asserted-by":"publisher","first-page":"1451574","DOI":"10.3389\/fchem.2024.1451574","volume":"12","author":"X Zhang","year":"2024","unstructured":"Zhang X, Zheng X, Han C, Wu L. Structure-based virtual screening towards the discovery of novel thrombin inhibitors with Anti-HCC activities. Front Chem. 2024;12:1451574","journal-title":"Front Chem"},{"key":"11117_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.116018","volume":"170","author":"ZS Xie","year":"2024","unstructured":"Xie ZS, Han XY, Zhou ZY, Li SY, Zhu JY, Zhang L, et al. Design and synthesis of dabigatran etexilate derivatives with inhibiting thrombin activity for hepatocellular carcinoma treatment. Biomed Pharmacother. 2024;170: 116018","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"11117_CR43","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3350\/cmh.2022.0095","volume":"29","author":"T Nakatsuka","year":"2023","unstructured":"Nakatsuka T, Tateishi R. Development and prognosis of hepatocellular carcinoma in patients with diabetes. Clin Mol Hepatol. 2023;29(1):51\u201364","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"11117_CR44","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cld.2011.03.007","volume":"15","author":"A Siddique","year":"2011","unstructured":"Siddique A, Kowdley KV. Insulin resistance and other metabolic risk factors in the pathogenesis of hepatocellular carcinoma. Clin Liver Dis. 2011;15(2):281\u2013296","journal-title":"Clin Liver Dis"},{"issue":"Suppl 1","key":"11117_CR45","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1160\/THS10-11-0739","volume":"105","author":"K Hess","year":"2011","unstructured":"Hess K, Grant PJ. Inflammation and thrombosis in diabetes. Thromb Haemost. 2011;105(Suppl 1):S43-54","journal-title":"Thromb Haemost"},{"issue":"1 Suppl","key":"11117_CR46","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1016\/j.jhep.2016.02.021","volume":"64","author":"M Levrero","year":"2016","unstructured":"Levrero M, Zucman-Rossi J. Mechanisms of HBV-induced hepatocellular carcinoma. J Hepatol. 2016;64(1 Suppl):S84-s101","journal-title":"J Hepatol"},{"issue":"9","key":"11117_CR47","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.3390\/jcm12093336","volume":"12","author":"J-J Yoo","year":"2023","unstructured":"Yoo J-J, Park MY, Cho EJ, Yu SJ, Kim SG, Kim YJ, et al. Smoking Increases the risk of hepatocellular carcinoma and cardiovascular disease in patients with metabolic-associated Fatty liver disease. J Clin Med. 2023;12(9):3336","journal-title":"J Clin Med"},{"issue":"9","key":"11117_CR48","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1097\/COC.0000000000000388","volume":"41","author":"A Gupta","year":"2018","unstructured":"Gupta A, Das A, Majumder K, Arora N, Mayo HG, Singh PP, et al. Obesity is Independently associated with increased risk of hepatocellular cancer-related mortality: a systematic review and meta-analysis. Am J Clin Oncol. 2018;41(9):874\u2013881","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"11117_CR49","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2018-000260","volume":"6","author":"H Matsushita","year":"2019","unstructured":"Matsushita H, Takaki A. Alcohol and hepatocellular carcinoma. BMJ Open Gastroenterol. 2019;6(1): e000260","journal-title":"BMJ Open Gastroenterol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-026-11117-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-026-11117-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-026-11117-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:03:54Z","timestamp":1787681034000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-026-11117-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":49,"alternative-id":["11117"],"URL":"https:\/\/doi.org\/10.1007\/s12072-026-11117-0","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In this article, the affiliation for Author Yu-Wen Su was missing, and it has now been added.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Yu-Wen Su, Yu-Hsuan Pai, Yao-Min Hung, Fuu-Jen Tsai, Renin Chang, Sung-Shuo Kao. have authors have no competing interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}